Japanese Council Delays Approving Epadel Switch OTC
This article was originally published in PharmAsia News
Executive Summary
The subcommittee on over-the-counter drugs at Japan's Ministry of Health, Labor and Welfare decided to delay approving hyperlipidemia drug Epadel (ethyl icosapentate) switch to OTC